Terminated PHASE2 INTERVENTIONAL 5-arm NCT00835718

A Study of MK0594 in Patients With Alcohol Dependence (0594-020)

A Phase II Multicenter, Randomized, Double-Blind, Two-Stage Clinical Trial to Evaluate the Efficacy and Safety of MK0594 in Patients With Alcohol Dependence

Sponsor: Vyne Therapeutics Inc.

Conditions Alcohol Dependence

Interventions Comparator: MK0594 1 mg/day Comparator: MK0594 1 mg/week Comparator: MK0594 5 mg/day Comparator: Placebo to MK0594

Updated 10 times since 2017 Last updated: May 18, 2021 Started: Feb 27, 2009 Primary completion: Mar 11, 2010 Completion: Mar 11, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

This trial was terminated. No reason was provided.

Other terminated trials from Vyne Therapeutics Inc.

More terminations from Vyne Therapeutics Inc.

Other Alcohol Dependence trials with similar outcome

Browse all Alcohol Dependence trials

Listed as NCT00835718, this PHASE2 trial focuses on Alcohol Dependence and remains terminated or withdrawn. Sponsored by Vyne Therapeutics Inc., it has been updated 10 times since 2009, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Apr 2022 — Jul 2024 [monthly]

Terminated PHASE2
Jun 2021 — Apr 2022 [monthly]

Terminated PHASE2
Jan 2021 — Jun 2021 [monthly]

Terminated PHASE2

▶ Show 5 earlier versions

Sep 2020 — Jan 2021 [monthly]

Terminated PHASE2
Aug 2020 — Sep 2020 [monthly]

Terminated PHASE2
Jun 2018 — Aug 2020 [monthly]

Terminated PHASE2
Feb 2017 — Jun 2018 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Feb 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Vyne Therapeutics Inc.

Data source: Vyne Therapeutics Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.